Pink Biopharma

Monoclonal Antibody Therapy for Blood and Bone Cancer

Health Tech & Life Sciences

Non Active, Jul 2021 ceased to operate

Seed Founded 2018

Total raised

$3.0M

Last: Seed 2018-10

Stage

Seed

Founded

2018

Headcount

Sector

Health Tech & Life Sciences

About

Pink Biopharma is a drug-discovery company that is developing a therapeutic monoclonal antibody as a natural-killer immune checkpoint inhibitor for a variety of cancers, specifically acute myeloid leukemia. The company is a portfolio company of the FutuRx biotech incubator.

Funding history · 1 round · $3.0M total

2018-10

Seed $3.0M

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Technologies

Biologicals

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business model

B2B

Name	Pink Biopharma
Slug	pink-biopharma
Type	Israeli Startup
Founded	2018
HQ city
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Seed
Public stage	Seed
Total raised (USD)	3,000,000
Last round	Seed (2018-10)
Israeli Companies Registrar	515850006

Name	Role	LinkedIn
Rachel Eren
Yael Yoffe-Mizrahi
Prof. Angel Porgador

Pink Biopharma

About

Funding history · 1 round · $3.0M total

Sectors & technology

Tags

Pink Biopharma — Full Company Profile (machine-readable)

About

Facts

Funding rounds (1)

Team (3)

About

Funding history · 1 round · $3.0M total

Sectors & technology

Tags

Generate Slim Page